J Glob Antimicrob Resist
March 2021
Objectives: We sought to identify risk factors associated with vancomycin-resistant Enterococcus faecium (VRE) and ampicillin-resistant Enterococcus faecalis (ARE) bacteraemia, predictors of 30-day mortality, and 90-day recurrence-free survival according to resistance.
Methods: We evaluated clinical records of patients with E. faecalis and E.
Aim: In this study, we conducted a comparative study to explore the differences in therapeutic efficacy and intestinal microbiome of fecal microbiota transplant (FMT) FMT in addition with (FMT-L) for treatment of recurrent infection (R-CDI).
Methods: We designed a double-blinded randomized comparative two-arm pilot multicenter study to assess the efficacy and impact in the intestinal microbiome of standard capsules of FMT FMT-L enriched with 3 species of for patients with R-CDI. A 90-day follow-up of 21 patients was performed, starting at the beginning of the study.